As the mental health crisis continues to surge in the U.S., it’s more important than ever to raise awareness about the impact ...

Researchers are investigating the potential use of virtual reality in the treatment of major depressive disorder — the ...

Investigators used data from the Taiwan national health insurance database to evaluate the susceptibility to TRD within families and its associated health outcomes.

Oregon ranks dead last in balancing the prevalence of youth mental illness with access to care, given high rates of youth ...

Individuals who sleep more on weekends, known as weekend catch-up sleep, show significantly fewer depressive symptoms, ...

A high burden of HIV could indicate other underlying factors, such as limited access to health care resources and a risk of ...

The FDA has approved the first app for treating major depressive disorder, a condition estimated to impact 21% of U.S. adults at some point in their lifetime. The app, Rejoyn, is intended to ...

In an exploratory clinical trial, four male patients diagnosed with major depressive disorder underwent eight weeks of treatment with a device that generates a low-frequency ultralow magnetic field ...

"One in five women report experiencing elevated depressive symptoms within the year after giving birth," said lead author ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Gilgamesh Pharmaceuticals has commenced subject dosing in a Phase IIa clinical trial of GM-1020 to treat major depressive ...

This multiyear study examined the prevalence of depressive symptoms in college athletes, as well as demographic factors related to increased or decreased rates of depressive symptoms by gender and ...